
USFDA APPLICATION NUMBER - 11757 / DOSAGE - INJECTABLE;INJECTION - 40MG/ML
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| METHYLPREDNISOLONE ACETATE(UNII: 43502P7F0P) (METHYLPREDNISOLONE - UNII:X4W7ZR7023) | METHYLPREDNISOLONE ACETATE | 40mg |
Inactive Ingredients
| Ingredient Name | A-S Medication Solutions | Northstar RxLLC | Pharmacia & Upjohn Company LLC | Pharmacia and Upjohn Company LLC | REMEDYREPACK INC. | Sandoz Inc | Teva Parenteral Medicines, Inc. | RX PHARMA-PACK, INC. | Cardinal Health | Terrain Pharmaceuticals |
|---|---|---|---|---|---|---|---|---|---|---|
| BENZYL ALCOHOL(LKG8494WBH) | ||||||||||
| CITRIC ACID MONOHYDRATE(2968PHW8QP) | ||||||||||
| HYDROCHLORIC ACID(QTT17582CB) | ||||||||||
| MIRIPIRIUM CHLORIDE(3D6CWI0P23) | ||||||||||
| NONOXYNOL-9(48Q180SH9T) | ||||||||||
| POLYETHYLENE GLYCOL 3350(G2M7P15E5P) | ||||||||||
| POLYSORBATE 80(6OZP39ZG8H) | ||||||||||
| SODIUM CHLORIDE(451W47IQ8X) | ||||||||||
| SODIUM HYDROXIDE(55X04QC32I) | ||||||||||
| SODIUM PHOSPHATE, DIBASIC(GR686LBA74) | ||||||||||
| SODIUM PHOSPHATE, DIBASIC, ANHYDROUS(22ADO53M6F) | ||||||||||
| SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM(GR686LBA74) | ||||||||||
| SODIUM PHOSPHATE, MONOBASIC(3980JIH2SW) | ||||||||||
| SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE(593YOG76RN) | ||||||||||
| SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM(3980JIH2SW) | ||||||||||
| WATER(059QF0KO0R) |